Advice
Development of this evidence summary
Development of this evidence summary
This evidence summary has been developed by Bazian Ltd. The Interim process statement sets out the process NICE uses to select topics for the evidence summaries for unlicensed/off-label medicines and how the summaries are developed, quality assured and approved for publication.
Peer reviewers and contributors
Victoria Thomas, Patient and Public Involvement Programme, NICE
Justin Slagel, S.L.A. Pharma (UK) Ltd